A Study to Evaluate Efficacy of Ramosetron on Diarrhea-predominant Irritable Bowel Syndrome (IBS) in Male Patients

NCT01225237 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

296

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritable Bowel Syndrome

Interventions

DRUG: Ramosetron
DRUG: Placebo

Sponsor

Astellas Pharma Inc